Etanercept
Brand name: Enbrel Sureclick
Rank #14 of 500 drugs by total cost
$1.12B
Total Cost
145,737
Total Claims
$1.12B
Total Cost
4,204
Prescribers
$7,682
Cost per Claim
7,027
Beneficiaries
154,601
30-Day Fills
$266K
Avg Cost/Provider
35
Avg Claims/Provider
About Etanercept
Etanercept (sold as Enbrel Sureclick) was prescribed 145,737 times by 4,204 Medicare Part D providers in 2023, costing the program $1.12B. At $7,682 per claim, this is a high-cost medication.
💰 This drug alone accounts for 0.4% of all Medicare Part D drug spending.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 11 | Sitagliptin Phosphate (Januvia) | $1.54B | 1,567,668 |
| 12 | Sacubitril/Valsartan (Entresto) | $1.30B | 1,220,812 |
| 13 | Bictegrav/Emtricit/Tenofov Ala (Biktarvy) | $1.29B | 310,738 |
| 14 | Etanercept (Enbrel Sureclick) | $1.12B | 145,737 |
| 15 | Enzalutamide (Xtandi) | $985.0M | 72,710 |
| 16 | Mirabegron (Myrbetriq) | $927.5M | 1,407,073 |
| 17 | Tirzepatide (Mounjaro) | $877.9M | 680,457 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology